2019 CPT-4 and HCPCS codes subject to CLIA edits
2019 CPT-4 and HCPCS Codes Subject to CLIA Edits
Includes non-waived and non-PPMP tests Laboratory certification codes are for informational purposes only.
CPT only copyright 2018 American Medical Association. All rights reserved CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
HCPCS
G0103 G0123 G0124 G0141 G0143 G0144 G0145 G0147 G0148 G0306 G0307 G0328 G0416 G0416 G0416 G0432 G0433 G0435 G0472
G0475 G0476 G0480 G0481 G0482 G0483 G0499 G0659 G9143 P3000 P3001 P7001 0111T
0001U
0002U
0003U
0005U
0006U
0007U
MOD DESCRIPTION
Psa, screening Screen cerv/vag thin layer Screen c/v thin layer by MD Scr c/v cyto,autosys and md Scr c/v cyto,thinlayer,rescr Scr c/v cyto,thinlayer,rescr Scr c/v cyto,thinlayer,rescr Scr c/v cyto, automated sys Scr c/v cyto, autosys, rescr CBC/diffwbc w/o platelet CBC without platelet Fecal blood scrn immunoassay Prostate biopsy, any mthd TC Prostate biopsy, any mthd 26 Prostate biopsy, any mthd EIA HIV-1/HIV-2 screen ELISA HIV-1/HIV-2 screen Oral HIV-1/HIV-2 screen Hepatitis c antibody screening, for individual at high risk and other covered indication(s) Hiv combination assay Hpv combo assay ca screen Drug test def 1-7 classes Drug test def 8-14 classes Drug test def 15-21 classes Drug test def 22+ classes Hepb screen high risk indiv Drug test def simple all cl Warfarin respon genetic test Screen pap by tech w md supv Screening pap smear by phys Culture bacterial urine Long-chain omega-3 fatty acids in red blood cell membranes
Rbc dna hea 35 ag 11 bld grp
Onc clrct 3 ur metab alg plp
Onc ovar 5 prtn ser alg scor
Onco prst8 3 gene ur alg
Detc ia meds 120+ analytes
Rx test prsmv ur w/def conf
LABORATORY CERTIFICATION (LC) CODE
310 630 630 630 630 630 630 630 630 400 400 310, 400 610 610 610 140, 220 140, 220 140, 220 220
140, 220 140 340 340 340 340 220 340
220, 310 630 630 110
310
510
220, 310
220, 310
220, 310
340
340
HCPCS
0008U 0009U 0010U 0011U 0012U 0013U 0014U 0016U 0017U 0018U
0019U 0020U 0021U 0022U 0023U 0024U 0025U 0026U 0027U 0028U 0029U 0030U 0031U 0032U 0033U 0034U 0035U 0036U 0037U 0038U 0039U 0040U
0041U 0042U 0043U 0044U 0045U 0046U 0047U 0048U 0049U
MOD DESCRIPTION
Hpylori detcj abx rstnc dna Onc brst ca erbb2 amp/nonamp Nfct ds strn typ whl gen seq Rx mntr lc-ms/ms oral fluid Germln do gene reargmt detcj Onc sld org neo gene reargmt Hem hmtlmf neo gene reargmt Onc hmtlmf neo rna bcr/abl1 Onc hmtlmf neo jak2 mut dna MicroRNA gene analysis of thyroid nodule tissue - Effective 10/1/2017 RNA gene analysis of tumor tissue - Effective 10/1/2017 Rx test prsmv ur w/def conf - Discontinued 9/30/2018 Onc prst8 detcj 8 autoantb - Effective 10/1/2017 Trgt gen seq dna&rna 23 gene - Effective 10/1/2017 Onc aml dna detcj/nondetcj - Effective 10/1/2017 Glyca nuc mr spectrsc quan - Effective 1/1/2019 Tenofovir liq chrom ur quan - Effective 1/1/2019 Onc thyr dna&mrna 112 genes - Effective 1/1/2019 Jak2 gene trgt seq alys - Effective 1/1/2019 Cyp2d6 gene cpy nmr cmn vrnt - Discontinued 9/30/2018 Rx metab advrs trgt seq alys - Effective 1/1/2019 Rx metab warf trgt seq alys - Effective 1/1/2019 Cyp1a2 gene - Effective 1/1/2019 Comt gene - Effective 1/1/2019 Htr2a htr2c genes - Effective 1/1/2019 Tpmt nudt15 genes - Effective 1/1/2019 Neuro csf prion prtn qual - Effective 4/1/2018 Xome tum & nml spec seq alys - Effective 4/1/2018 Trgt gen seq dna 324 genes - Effective 4/1/2018 Vitamin d srm microsamp quan - Effective 4/1/2018 Dna antb 2strand hi avidity - Effective 4/1/2018 Gene analysis (t(9;22)) for translocation analysis - Effective 4/1/2018 B brgdrferi antb 5 prtn igm - Effective 4/1/2018 B brgdrferi antb 12 prtn igg - Effective 4/1/2018 Tbrf b grp antb 4 prtn igm - Effective 4/1/2018 Tbrf b grp antb 4 prtn igg - Effective 4/1/2018 Onc brst dux carc is 12 gene - Effective 7/1/2018 Flt3 gene itd variants quan - Effective 7/1/2018 Onc prst8 mrna 17 gene alg - Effective 7/1/2018 Onc sld org neo dna 468 gene - Effective 7/1/2018 Npm1 gene analysis quan - Effective 7/1/2018
LABORATORY CERTIFICATION (LC) CODE
110 220, 310
110 340 220, 310 220, 310 400 220, 310, 400 220, 310, 400
220, 310 220, 310
340 220, 310 220, 310 220, 310, 400 220, 310 220, 310 220, 310 310, 900 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310
310 220, 310 220, 310
310 220
220, 310, 400 220 220 220 220
220, 310 220, 310, 410
220, 310 220, 310 220, 310, 410
CPT only copyright 2018 American Medical Association. All rights reserved.
2
HCPCS
0050U 0051U 0052U 0053U 0054U 0055U 0056U 0057U 0058U 0059U 0060U 0062U 0063U 0064U 0065U 0066U 0067U 0068U 0069U 0070U 0071U 0072U 0073U 0074U 0075U 0076U 0077U 0078U 0080U
0081U
MOD DESCRIPTION
LABORATORY CERTIFICATION (LC) CODE
Trgt gen seq dna 194 genes - Effective 7/1/2018
220, 310, 410
Rx mntr lc-ms/ms ur 31 pnl - Effective 7/1/2018
340
Lpoprtn bld w/5 maj classes - Effective 7/1/2018
310
Onc prst8 ca fish alys 4 gen - Effective 7/1/2018
220, 310
Rx mntr 14+ drugs & sbsts - Effective 7/1/2018
340
Card hrt trnspl 96 dna seq - Effective 7/1/2018
220, 310
Hem aml dna gene reargmt - Effective 7/1/2018
400
Onc sld org neo mrna 51 gene - Effective 7/1/2018
220, 310
Onc merkel cll carc srm quan - Effective 7/1/2018
220, 310
Onc merkel cll carc srm +/- - Effective 7/1/2018
220, 310
Twn zyg gen seq alys chrms2 - Effective 7/1/2018
900
Ai sle igg&igm alys 80 bmrk - Effective 10/1/2018
220, 310
Neuro autism 32 amines alg - Effective 10/1/2018
220, 310, 900
Antb tp total&rpr ia qual - Effective 10/1/2018
210
Syfls tst nontreponemal antb - Effective 10/1/2018
210
Pamg-1 ia cervico-vag fluid - Effective 10/1/2018
310
Onc brst imhchem prfl 4 bmrk - Effective 10/1/2018
220, 310
Candida species pnl amp prb - Effective 10/1/2018
120
Onc clrct microrna mir-31-3p - Effective 10/1/2018
220, 310
Cyp2d6 gen com&slct rar vrnt - Effective 10/1/2018
220, 310
Cyp2d6 full gene sequence - Effective 10/1/2018
220, 310
Cyp2d6 gen cyp2d6-2d7 hybrid - Effective 10/1/2018
220, 310
Cyp2d6 gen cyp2d7-2d6 hybrid - Effective 10/1/2018
220, 310
Cyp2d6 nonduplicated gene - Effective 10/1/2018
220, 310
Cyp2d6 5' gene dup/mlt - Effective 10/1/2018
220, 310
Cyp2d6 3' gene dup/mlt - Effective 10/1/2018
220, 310
Ig paraprotein qual bld/ur - Effective 10/1/2018
310
Pain mgt opi use gnotyp pnl - Effective 10/1/2018
220, 310
Oncology (lung), mass spectrometric analysis of galectin-3-
220, 310
binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smoking status,
nodule diameter, nodule-spiculation status and nodule location),
utilizing plasma, algorithm reported as a categorical probability
of malignancy - Effective 1/1/2019
Oncology (uveal melanoma), mRNA, gene-expression profiling
220, 310
by real-time RT-PCR of 15 genes (12 content and 3
housekeeping genes), utilizing fine needle aspirate or formalin-
fixed paraffin-embedded tissue, algorithm reported as risk of
metastasis - Effective 1/1/2019
CPT only copyright 2018 American Medical Association. All rights reserved.
3
HCPCS
0082U
0083U
17311 17312 17313 17314 17315 78110 78110 78110 78111 78111 78111 78120 78120 78120 78121 78121 78121 78122 78122 78122 78130 78130 78130 78191 78191 78191 78270 78270 78270 78271 78271 78271 78272 78272 78272 80047 80048 80050
MOD
TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26 TC 26
DESCRIPTION
Drug test(s), definitive, 90 or more drugs or substances, definitive chromatography with mass spectrometry, and presumptive, any number of drug classes, by instrument chemistry analyzer (utilizing immunoassay), urine, report of presence or absence of each drug, drug metabolite or substance with description and severity of significant interactions per date of service - Effective 1/1/2019
Oncology, response to chemotherapy drugs using motility contrast tomography, fresh or frozen tissue, reported as likelihood of sensitivity or resistance to drugs or drug combinations - Effective 1/1/2019
Mohs, 1 stage, h/n/hf/g Mohs addl stage Mohs, 1 stage, t/a/l Mohs, addl stage, t/a/l Mohs surg, addl block Plasma volume, single Plasma volume, single Plasma volume single Plasma volume, multiple Plasma volume, multiple Plasma volume multiple Red cell mass, single Red cell mass, single Red cell mass single Red cell mass, multiple Red cell mass, multiple Red cell mass multiple Blood volume Blood volume Blood volume Red cell survival study Red cell survival study Red cell survival study Platelet survival Platelet survival Platelet survival Vit B-12 absorption exam - Discontinued 12/31/2018 Vit B-12 absorption exam - Discontinued 12/31/2018 Vit B-12 absorption exam - Discontinued 12/31/2018 Vit B-12 absorp exam, int fac - Discontinued 12/31/2018 Vit B-12 absorp exam, int fac - Discontinued 12/31/2018 Vit b-12 absrp exam int fac - Discontinued 12/31/2018 Vit B-12 absorp, combined - Discontinued 12/31/2018 Vit B-12 absorp, combined - Discontinued 12/31/2018 Vit b-12 absorp combined - Discontinued 12/31/2018 Metabolic panel ionized ca Metabolic panel total ca General health panel - Not payable by Medicare
LABORATORY CERTIFICATION (LC) CODE
340
220, 310
610 610 610 610 610 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 800 310 310 310, 330, 400
CPT only copyright 2018 American Medical Association. All rights reserved.
4
HCPCS
80051 80053 80055 80061 80069 80074 80076 80081 80150 80155 80156 80157 80158 80159 80162 80163 80164 80165 80168 80169 80170 80171 80173 80175 80176 80177 80178 80180 80183 80184 80185 80186 80188 80190 80192 80194 80195 80197 80198 80199 80200 80201 80202 80203 80299 80305 80306 80307 80320 80321
MOD DESCRIPTION
Electrolyte panel Comprehen metabolic panel Obstetric panel - Not valid for Medicare Lipid panel Renal function panel Acute hepatitis panel Hepatic function panel Obstetric panel Assay of amikacin Drug assay caffeine Assay, carbamazepine, total Assay, carbamazepine, free Drug assay cyclosporine Drug assay clozapine Assay of digoxin total Assay of digoxin free Assay dipropylacetic acd tot Dipropylacetic acid free Assay of ethosuximide Drug screen quant everolimus Assay of gentamicin Drug screen quant gabapentin Assay of haloperidol Drug screen quan lamotrigine Assay of lidocaine Drug scrn quan levetiracetam Assay of lithium Drug scrn quan mycophenolate Drug scrn quant oxcarbazepin Assay of phenobarbital Assay of phenytoin, total Assay of phenytoin, free Assay of primidone Assay of procainamide Assay of procainamide Assay of quinidine Assay of sirolimus Assay of tacrolimus Assay of theophylline Drug screen quant tiagabine Assay of tobramycin Assay of topiramate Assay of vancomycin Drug screen quant zonisamide Quantitative assay, drug Drug test prsmv dir opt obs Drug test prsmv instrmnt Drug test prsmv chem anlyzr Drug screen quantalcohols - Not payable by Medicare Alcohols biomarkers 1or 2 - Not payable by Medicare
LABORATORY CERTIFICATION (LC) CODE
310 310 210, 220, 400, 530 310 310 220 310 210, 220, 400, 510, 520 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340
CPT only copyright 2018 American Medical Association. All rights reserved.
5
HCPCS
80322 80323 80324 80325 80326 80327 80328 80329 80330 80331 80332 80333 80334 80335 80336 80337 80338 80339 80340 80341 80342 80343 80344 80345 80346 80347 80348 80349 80350 80351 80352 80353 80354 80355 80356 80357 80358 80359 80360 80361 80362 80363 80364 80365 80366 80367 80368 80369 80370 80371
MOD DESCRIPTION
Alcohols biomarkers 3/more - Not payable by Medicare Alkaloids nos - Not payable by Medicare Drug screen amphetamines 1/2 - Not payable by Medicare Amphetamines 3or 4 - Not payable by Medicare Amphetamines 5 or more - Not payable by Medicare Anabolic steroid 1 or 2 - Not payable by Medicare Anabolic steroid 3 or more - Not payable by Medicare Analgesics non-opioid 1 or 2 - Not payable by Medicare Analgesics non-opioid 3-5 - Not payable by Medicare Analgesics non-opioid 6/more - Not payable by Medicare Antidepressants class 1 or 2 - Not payable by Medicare Antidepressants class 3-5 - Not payable by Medicare Antidepressants class 6/more - Not payable by Medicare Antidepressant tricyclic 1/2 - Not payable by Medicare Antidepressant tricyclic 3-5 - Not payable by Medicare Tricyclic & cyclicals 6/more - Not payable by Medicare Antidepressant not specified - Not payable by Medicare Antiepileptics nos 1-3 - Not payable by Medicare Antiepileptics nos 4-6 - Not payable by Medicare Antiepileptics nos 7/more - Not payable by Medicare Antipsychotics nos 1-3 - Not payable by Medicare Antipsychotics nos 4-6 - Not payable by Medicare Antipsychotics nos 7/more - Not payable by Medicare Drug screening barbiturates - Not payable by Medicare Benzodiazepines1-12 - Not payable by Medicare Benzodiazepines 13 or more - Not payable by Medicare Drug screening buprenorphine - Not payable by Medicare Cannabinoids natural - Not payable by Medicare Cannabinoids synthetic 1-3 - Not payable by Medicare Cannabinoids synthetic 4-6 - Not payable by Medicare Cannabinoid synthetic 7/more - Not payable by Medicare Drug screening cocaine - Not payable by Medicare Drug screening fentanyl - Not payable by Medicare Gabapentin non-blood - Not payable by Medicare Heroin metabolite - Not payable by Medicare Ketamine and norketamine - Not payable by Medicare Drug screening methadone - Not payable by Medicare Methylenedioxyamphetamines - Not payable by Medicare Methylphenidate - Not payable by Medicare Opiates 1 or more - Not payable by Medicare Opioids & opiate analogs 1/2 - Not payable by Medicare Opioids & opiate analogs 3/4 - Not payable by Medicare Opioid &opiate analog 5/more - Not payable by Medicare Drug screening oxycodone - Not payable by Medicare Drug screening pregabalin - Not payable by Medicare Drug screening propoxyphene - Not payable by Medicare Sedative hypnotics - Not payable by Medicare Skeletal muscle relaxant 1/2 - Not payable by Medicare Skel musc relaxant 3 or more - Not payable by Medicare Stimulants synthetic - Not payable by Medicare
LABORATORY CERTIFICATION (LC) CODE
340 340 340 340 340 330 330 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340 340
CPT only copyright 2018 American Medical Association. All rights reserved.
6
HCPCS
80372 80373 80374 80375 80376 80377 80400 80402 80406 80408 80410 80412 80414 80415 80416 80417 80418 80420 80422 80424 80426 80428 80430 80432 80434 80435 80436 80438 80439 81003 81005 81007 81099 81105 81106 81107 81108 81109 81110 81111 81112 81120 81121 81161 81162 81163 81164 81165 81166 81167
MOD DESCRIPTION
Drug screening tapentadol - Not payable by Medicare Drug screening tramadol - Not payable by Medicare Stereoisomer analysis - Not payable by Medicare Drug/substance nos 1-3 - Not payable by Medicare Drug/substance nos 4-6 - Not payable by Medicare Drug/substance nos 7/more - Not payable by Medicare Acth stimulation panel Acth stimulation panel Acth stimulation panel Aldosterone suppression eval Calcitonin stimul panel CRH stimulation panel Testosterone response Estradiol response panel Renin stimulation panel Renin stimulation panel Pituitary evaluation panel Dexamethasone panel Glucagon tolerance panel Glucagon tolerance panel Gonadotropin hormone panel Growth hormone panel Growth hormone panel Insulin suppression panel Insulin tolerance panel Insulin tolerance panel Metyrapone panel TRH stimulation panel TRH stimulation panel Urinalysis, auto, w/o scope Urinalysis Urine screen for bacteria Urinalysis test procedure Hpa-1 genotyping Hpa-2 genotyping Hpa-3 genotyping Hpa-4 genotyping Hpa-5 genotyping Hpa-6 genotyping Hpa-9 genotyping Hpa-15 genotyping Idh1 common variants Idh2 common variants Dmd dup/delet analysis Brca1&2 seq & full dup/del Brca1&2 gene full seq alys - Effective 1/1/2019 Brca1&2 gen ful dup/del alys - Effective 1/1/2019 Brca1 gene full seq alys - Effective 1/1/2019 Brca1 gene full dup/del alys - Effective 1/1/2019 Brca2 gene full dup/del alys - Effective 1/1/2019
LABORATORY CERTIFICATION (LC) CODE
340 340 340 340 340 340 330 330 330 330 330 330 330 330 330 330 330 330 310, 330 310, 330 330 330 310, 330 310, 330 310, 330 310, 330 330 330 330 320 320 110 320 400 400 400 400 400 400 400 400 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310
CPT only copyright 2018 American Medical Association. All rights reserved.
7
HCPCS
81170 81171 81172 81173 81174 81175 81176 81177 81178 81179 81180 81181 81182 81183 81184 81185 81186 81187 81188 81189 81190 81200 81201 81202 81203 81204 81205 81206 81207 81208 81209 81210 81211 81212 81213 81214 81215 81216 81217 81218 81219 81220 81221 81222 81223 81224 81225 81226 81227 81228
MOD DESCRIPTION
Abl1 gene Aff2 gene detc abnor alleles - Effective 1/1/2019 Aff2 gene charac alleles - Effective 1/1/2019 Ar gene full gene sequence - Effective 1/1/2019 Ar gene known famil variant - Effective 1/1/2019 Asxl1 full gene sequence Asxl1 gene target seq alys Atn1 gene detc abnor alleles - Effective 1/1/2019 Atxn1 gene detc abnor allele - Effective 1/1/2019 Atxn2 gene detc abnor allele - Effective 1/1/2019 Atxn3 gene detc abnor allele - Effective 1/1/2019 Atxn7 gene detc abnor allele - Effective 1/1/2019 Atxn8os gen detc abnor allel - Effective 1/1/2019 Atxn10 gene detc abnor allel - Effective 1/1/2019 Cacna1a gen detc abnor allel - Effective 1/1/2019 Cacna1a gene full gene seq - Effective 1/1/2019 Cacna1a gen known famil vrnt - Effective 1/1/2019 Cnbp gene detc abnor allele - Effective 1/1/2019 Cstb gene detc abnor allele - Effective 1/1/2019 Cstb gene full gene sequence - Effective 1/1/2019 Cstb gene known famil vrnt - Effective 1/1/2019 Aspa gene Apc gene full sequence Apc gene known fam variants Apc gene dup/delet variants Ar gene charac alleles - Effective 1/1/2019 Bckdhb gene Bcr/abl1 gene major bp Bcr/abl1 gene minor bp Bcr/abl1 gene other bp Blm gene Braf gene Brca1&2 seq & com dup/del - Discontinued 12/31/2018 Brca1&2 185&5385&6174 var Brca1&2 uncom dup/del var - Discontinued 12/31/2018 Brca1 full seq & com dup/del - Discontinued 12/31/2018 Brca1 gene known fam variant Brca2 gene full sequence Brca2 gene known fam variant Cebpa gene full sequence Calr gene com variants Cftr gene com variants Cftr gene known fam variants Cftr gene dup/delet variants Cftr gene full sequence Cftr gene intron poly t Cyp2c19 gene com variants Cyp2d6 gene com variants Cyp2c9 gene com variants Cytogen micrarray copy nmbr
LABORATORY CERTIFICATION (LC) CODE
220, 310, 900 220, 310 220, 310 310, 330 310, 330 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 310, 330 220, 310
220, 310, 900 220, 310, 900 220, 310, 900
220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310, 900 220, 310, 900 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310 220, 310, 900
CPT only copyright 2018 American Medical Association. All rights reserved.
8
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- 2019 cpt 4 and hcpcs codes subject to clia edits
- triwest healthcare alliance provider authorization codes
- coding modifiers table
- 2019 x ray cpt codes
- list of country codes and locode mainfreight singapore
- 2018 cardiology reimbursement coding fact sheet
- 2019 radiology cpt codes dca
- medicare ub 04 revenue codes
- cpt category ii codes home
- tests granted waived status under clia cpt code s